Recruiting
Phase 1
Phase 2

Zanubrutinib & Tafasitamab

Sponsor:

Alvaro Alencar, MD

Code:

NCT06029309

Conditions

Mantle Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib

Tafasitamab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-16. This information was provided to ClinicalTrials.gov by Alvaro Alencar, MD on 2025-04-23.